Compare OMC & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMC | WAT |
|---|---|---|
| Founded | 1944 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9B | 29.3B |
| IPO Year | 1994 | 1996 |
| Metric | OMC | WAT |
|---|---|---|
| Price | $78.88 | $319.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 17 |
| Target Price | $98.71 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 4.1M | 836.2K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.13% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | N/A | ★ 10.76 |
| Revenue | ★ $17,271,900,000.00 | $3,165,286,000.00 |
| Revenue This Year | $46.82 | $104.66 |
| Revenue Next Year | $0.47 | $10.42 |
| P/E Ratio | ★ N/A | $30.33 |
| Revenue Growth | ★ 10.09 | 6.99 |
| 52 Week Low | $66.33 | $275.05 |
| 52 Week High | $87.17 | $414.15 |
| Indicator | OMC | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.32 | 54.99 |
| Support Level | $77.52 | $282.76 |
| Resistance Level | $80.90 | $323.29 |
| Average True Range (ATR) | 1.85 | 8.93 |
| MACD | 0.42 | 3.71 |
| Stochastic Oscillator | 88.58 | 68.03 |
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.